CFTR
Showing 26 - 50 of 378
Cystic Fibrosis, Mucociliary Clearance Defect Trial in Iowa City, Columbia (Symptom driven performance of airway clearance,
Not yet recruiting
- Cystic Fibrosis
- Mucociliary Clearance Defect
- Symptom driven performance of airway clearance
- Continuous daily performance of airway clearance
-
Columbia, MissouriUniversity of Missouri Hospital and Clinics
Dec 12, 2022
Cystic Fibrosis Trial in Kansas City (Losartan)
Recruiting
- Cystic Fibrosis
-
Kansas City, KansasUniversity of Kansas Medical Center
Feb 15, 2022
People With Cystic Fibrosis Taking Highly Effective CFTR
Recruiting
- Cystic Fibrosis
-
Indianapolis, IndianaIndiana University School of Medicine
Sep 15, 2021
Cystic Fibrosis Trial in Newcastle (KB407 (Nebulization), KB407 (Intradermal))
Recruiting
- Cystic Fibrosis
- KB407 (Nebulization)
- KB407 (Intradermal)
-
Newcastle, New South Wales, AustraliaHunter Medical Research Institute
Jun 5, 2022
Cystic Fibrosis, Adherence, Medication Trial in Jerusalem, Haifa (ReX-C system)
Recruiting
- Cystic Fibrosis
- Adherence, Medication
- ReX-C system
-
Jerusalem, Select One, Israel
- +1 more
Sep 22, 2021
Response to CFTR Modulators in CF Patients Under 18 Years
Recruiting
- Cystic Fibrosis in Children
- CFTR Modulators
-
Paris, FranceSermet-Gaudelus Isabelle
Mar 19, 2021
Chronic Bronchitis Trial in Birmingham (Ivacaftor (VX-770))
Withdrawn
- Chronic Bronchitis
- Ivacaftor (VX-770)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Feb 1, 2022
Cystic Fibrosis, Biomarkers Trial in Bruxelles (Sweat test (Macroduct Sweat Collection System) and skin biopsy (Punch Biopsy))
Recruiting
- Cystic Fibrosis
- Biomarkers
- Sweat test (Macroduct Sweat Collection System) and skin biopsy (Punch Biopsy)
-
Bruxelles, Belgiumcliniques universitaires Saint-Luc
Mar 23, 2021
Cystic Fibrosis-related Diabetes, Cystic Fibrosis Trial in Kansas City (Metformin Hydrochloride)
Recruiting
- Cystic Fibrosis-related Diabetes
- Cystic Fibrosis
- Metformin Hydrochloride
-
Kansas City, KansasUniversity of Kansas Medical Center
Mar 1, 2022
Cystic Fibrosis Trial in United States (Tezacaftor/Ivacaftor, Ivacaftor, Tezacaftor/Ivacaftor matching )
Impact of Triple Combination CFTR Therapy on Sinus Disease.
Recruiting
- Cystic Fibrosis
- Elexacaftor-tezacaftor-ivacaftor exposure
-
Denver, ColoradoNational Jewish Health
Mar 9, 2021
Cystic Fibrosis Trial in Canada, United States (Initiation of CFTR Modulator)
Recruiting
- Cystic Fibrosis
- Initiation of CFTR Modulator
-
Cincinnati, Ohio
- +3 more
Aug 4, 2021
Cystic Fibrosis Trial in Worldwide (VX-371 + HS, Hypertonic saline, Placebo)
Completed
- Cystic Fibrosis
- VX-371 + HS
- +4 more
-
Little Rock, Arkansas
- +39 more
Jul 8, 2021
Biological & Clinical Effects of Significantly Corrected CFTR
Active, not recruiting
- Cystic Fibrosis
- Ivacaftor or elexacaftor/tezacaftor/ivacaftor
-
Birmingham, Alabama
- +33 more
Feb 2, 2022
Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI
Recruiting
- Cystic Fibrosis
- Hyperpolarized Xenon
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jun 16, 2021
Sweat Chloride and Their Association With Clinical Outcomes
Active, not recruiting
- Cystic Fibrosis
-
Birmingham, Alabama
- +51 more
Jun 16, 2022
Cystic Fibrosis Trial in Worldwide (TEZ/IVA, IVA)
Active, not recruiting
- Cystic Fibrosis
-
Birmingham, Alabama
- +54 more
Oct 28, 2022
Activation of p.Phe508del-CFTR by Lumacaftor in Combination With
Completed
- Cystic Fibrosis
- Lumacaftor plus Ivacaftor
-
Gießen, Germany
- +2 more
Jul 28, 2020
Biological and Clinical Effects of Significantly Corrected CFTR
Active, not recruiting
- Cystic Fibrosis
-
Birmingham, Alabama
- +55 more
Sep 7, 2022
The PROMISE Pediatric Study 6 to 11 Years Old
Active, not recruiting
- Cystic Fibrosis
- Cystic Fibrosis in Children
-
Birmingham, Alabama
- +19 more
Sep 7, 2022
Cystic Fibrosis Trial in Cincinnati (Initiation of CFTR Modulator, Hyperpolarized Xenon 129)
Recruiting
- Cystic Fibrosis
- Initiation of CFTR Modulator
- Hyperpolarized Xenon 129
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 16, 2020